Youngy Health Co Ltd

300247.CS▼

Rongjie Health's 2026 interim net profit was 44.2136 million yuan, down 6.97% year-on-year

Rongjie Health released its 2026 interim report. Total operating revenue was 395 million yuan, down 8.63% year-on-year. Net profit attributable to the parent company was 44.2136 million yuan, down 6.97% year-on-year. Net cash inflow from operating activities was 17.3489 million yuan, a sharp year-on-year decline of 73.33%. The company's asset-liability ratio was 16.13%, gross margin was 45.38%, return on equity was 3.76%, and diluted earnings per share was 0.06 yuan. The number of shareholders was 28,000, and the top ten shareholders held 28.84% of total share capital.

300247.CS ▼

Jiemian·24dRead more →

300247.CS▲2

Rongjie Health's holding subsidiary receives US tariff refund of 7.252 million dollars

Rongjie Health announced that its holding subsidiary Golden Designs Incorporated North America recently received cumulative US tariff refunds of 7.252 million dollars, including 6.9787 million dollars in refunded duties and 273,300 dollars in interest. According to a US Supreme Court ruling, the relevant US government tariff measures were void from the outset, and US Customs and Border Protection officially began refund processing on April 20, 2026. The refunds are expected to be recorded in current-period profit or loss for 2026, with an estimated impact on the company's net profit attributable to the parent of 17.9599 million yuan at the converted exchange rate, accounting for 24 percent of the company's most recent audited net profit.

300247.CS ▲

CLS·36dRead more →